Compare AdaptHealth Corp (AHCO) vs Progressive Corp (PGR) Price & Performance

AdaptHealth Corp. (AHCO) trades at $5.74, up 9.96% in the last session, yet remains under pressure with a bearish technical signal and recent earnings misses. The company reported a Q2 2026 net loss of $228 million with a -6.82% margin, while selling its diabetes unit to focus on sleep and respiratory care. Valuation ratios show a low P/S of 0.23 and P/B of 0.55, but negative profitability metrics highlight operational challenges.

The outlook is mixed: analyst consensus is bullish with a $11 price target, but risks include ongoing losses, fraud investigations, and cost overruns in fixed-price contracts. Upside depends on successful business restructuring and margin improvement, while downside risks from legal and execution issues persist.

PGR trades at $208.28, down 2.65% on the day, with a bearish technical signal. The stock shows strong fundamentals with a P/E of 10.65, net income margin of 12.85%, and robust revenue growth from $49.6B in 2022 to $87.6B in 2025. Recent Q2 2026 earnings beat expectations at $4.85 EPS, though Q1 2026 missed. Analyst consensus is a buy with a $231.20 price target, but technical indicators suggest near-term caution.

Outlook remains positive due to solid profitability and growth, but risks include competitive pressures and potential margin compression. The stock offers value at current levels with upside to analyst targets, though investors should monitor execution on growth initiatives and industry dynamics.